Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.84 USD | -2.15% | +3.28% | -30.00% |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 2.83M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.11
x | P/E ratio 2024 * |
-0.12
x | Employees | 18 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 95.63% |
Latest transcript on Eloxx Pharmaceuticals, Inc.
1 day | -2.15% | ||
1 week | +3.28% | ||
Current month | -12.60% | ||
1 month | -14.93% | ||
3 months | +10.38% | ||
6 months | -26.96% | ||
Current year | -30.00% |
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 20-10-31 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 14-04-30 |
Alan Walts
BRD | Director/Board Member | 64 | 21-03-31 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 0.84 | -2.15% | 1 277 |
24-05-15 | 0.8585 | -4.61% | 1,048 |
24-05-14 | 0.9 | 0.00% | 11,039 |
24-05-13 | 0.9 | -1.76% | 5,585 |
24-05-10 | 0.9161 | +12.64% | 32,213 |
Delayed Quote OTC Markets, May 16, 2024 at 11:12 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.00% | 2.83M | |
+7.81% | 113B | |
+10.90% | 106B | |
+0.41% | 22.27B | |
-11.89% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.63% | 17.24B | |
+6.76% | 14.29B | |
+35.78% | 12.52B |
- Stock Market
- Equities
- ELOX Stock